Shanghai Chest Hospital

This study tests whether adding two targeted drugs (pembrolizumab and bevacizumab) to standard chemotherapy can shrink tumors or slow cancer growth in people with advanced non-squamous lung cancer that has a specific EGFR exon 20 insertion mutation. The trial enrolled 54 adults w…

This study tests a daily pill called dacomitinib in 30 people with advanced non-small cell lung cancer that has uncommon EGFR gene mutations. The goal is to see if the drug shrinks tumors and controls the disease. Participants take the drug until their cancer worsens or they no l…

This study tests whether giving immunotherapy plus chemotherapy before the usual chemoradiation can help people with advanced esophageal cancer that cannot be surgically removed. About 50 adults with this type of cancer will receive the combination treatment, then chemoradiation.…

This study looks at tissue samples from 30 people who had surgery for esophageal cancer. Researchers want to measure how far cancer cells spread beyond the visible tumor edge. The goal is to better understand hidden cancer growth patterns, which could help improve future surgerie…